ENB-001

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameENB-001
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type B antagonists
TargetsEndothelin receptor type B
Therapy Area/IndicationsCarcinoma, Squamous CellMelanomaGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnb Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnb Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Squamous CellMelanomaGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A